Division of Gastroenterology, Rutgers Robert Wood Johnson University Hospital, 1 RWJ Place, MEB 464, New Brunswick, NJ, 08901, USA.
Dig Dis Sci. 2022 May;67(5):1649-1659. doi: 10.1007/s10620-022-07423-w. Epub 2022 Apr 4.
Pancreaticobiliary (PB) endotherapy continues to progress in the era of therapeutic endosonography. Endoscopic retrograde cholangiopancreatography (ERCP) remains the primary method for PB access in native and altered anatomy. In altered anatomy, PB access can be obtained via enteroscopy-assisted ERCP (e-ERCP) or laparoscopy-assisted ERCP; however, both approaches have significant limitations. Endoscopic ultrasound-guided biliary and pancreatic duct drainage (EUS-BPD) are increasingly becoming the preferred alternative when ERCP fails, with advantages over percutaneous drainage. EUS-BPD continues to evolve with better feasibility, safety and efficacy as dedicated procedural equipment continues to improve. In this article, we discuss the role of endoscopic ultrasound (EUS) when ERCP fails and their indications, technique, and outcomes.
在治疗性超声内镜时代,胰胆(PB)内镜治疗不断发展。经内镜逆行胰胆管造影术(ERCP)仍然是原发性和解剖结构改变的 PB 入路的主要方法。在解剖结构改变的情况下,可以通过小肠镜辅助 ERCP(e-ERCP)或腹腔镜辅助 ERCP 获得 PB 入路;然而,这两种方法都有很大的局限性。当 ERCP 失败时,超声内镜引导下胆管和胰管引流(EUS-BPD)越来越成为首选的替代方法,与经皮引流相比具有优势。随着专用程序设备的不断改进,EUS-BPD 继续发展,具有更好的可行性、安全性和疗效。本文讨论了 ERCP 失败时超声内镜的作用及其适应证、技术和结果。